Amgen Inc (NASDAQ: AMGN)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $363.39
-
Support level$353.01
-
Resistance levelN/A
-
Beta0.4
-
RSI (14-day)74.7
- Volatility is forecast to fall over the next month.
- AMGN is above its 200-day moving average, providing a measure of support for long positions.
- With RSI > 70, AMGN is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $271.18 | $388.16 | 81.6% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $337.51 | $343.61 | $356.44 | $364.60 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week6.3%
-
In the next month13.5%
-
In the next year52.6%
| Period | Value |
|---|---|
| Historical (5 year) | 23.8% |
| Last month | 23.1% |
| Current estimate | 23.3% |
| Next month forecast | 23.9% |